Recursion Pharmaceuticals filed documents with the SEC regarding CEO stock sales, while Morgan Stanley cut the price target for the company.

The entities involved

• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
• Recursion (United States) →

  company in Salt Lake City, United States

  • Recursion (United States) disclosed insider trading via required filings with the SEC on June 6, 2026.Sun 17:12
  • Trump's pledge to unleash oil and gas benefits stocks, involving Willis Towers Watson.Sun 05:14
• Securities and Exchange Commission →

  government agency of the Philippines

  • BlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Mon 16:42
  • Filing required regarding institutional holdings for Schwab Emerging Markets Equity ETF and Waterford Advisors LLC with the SEC.Mon 16:38

Related events

• MarketBeat is providing analyst ratings for Recursion Pharmaceuticals.Sep 20
• Primerica filed disclosures with the SEC regarding stock purchases while Keefe, Bruyette & Woods raised its price target.Sep 10
• Morgan Stanley, MSCI, Raymond James Financial, and Benzinga are involved in the process of receiving and issuing analyst ratings and research reports on company stocks.Jul 8
• Insider trading filings made with the SEC regarding Moderna stock sales by President Stephen Hoge.Aug 4
• Woodward filed reports with the Securities and Exchange Commission regarding its stock activity on August 19, 2026.Aug 19